Question Presented (from Petition)
I. Is authorization under the Controlled Substances Act defined in terms of the regulatory definition of an effective prescription or by the plain meaning of the statutory text?
II. Does the mens rea required under 21 U.S.C. § 841(a) and this Court's opinion in Ruan attach to the fact of non-authorization or to the regulatory standard for an effective prescription contained in 21 C.F.R. § 1306.04?
Question Presented (AI Summary)
Question not identified.
Docket Entries
2026-04-02
DISTRIBUTED for Conference of 4/17/2026.
2026-03-27
Waiver of United States of right to respond submitted.
2026-03-27
Waiver of right of respondent United States to respond filed.
2026-03-11
Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due April 16, 2026)
Attorneys
Hasna Bashir Iwas
Beau B. Brindley — The Law Offices of Beau B. Brindley, Petitioner
United States
D. John Sauer — Solicitor General, Respondent